Skip to main content
logo
NervGen Pharma Corp. (NGEN)
NASDAQ: NGEN · Real-Time Price · USD
1.395
+0.065 (4.89%)
At close: Nov 9, 2026, 4:00 PM EST
1.420
+0.025 (1.79%)
Pre-market: Nov 10, 2026, 7:07 AM EST

NervGen Pharma Cash Flow Statement

Millions CAD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-22.24-44.12-24.25-22.38-20.72-12.73
Depreciation & Amortization
0.060.060.080.150.120.04
Loss (Gain) From Sale of Assets
--0.01---
Stock-Based Compensation
5.895.396.046.042.774.02
Other Operating Activities
-6.2118.510.445.14-2.07-0.03
Change in Accounts Receivable
-0.10.33-0.17-0.220.04-0
Change in Accounts Payable
-0.88-0.271.23-0.072.320.32
Change in Other Net Operating Assets
-2.160.59-0.220.06-0.240.11
Operating Cash Flow
-25.65-19.5-16.84-11.3-17.78-8.27
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
----0.01-0.02-0
Sale of Property, Plant & Equipment
---0--
Sale (Purchase) of Intangibles
----0.14--0.04
Other Investing Activities
0.060.10.06---
Investing Cash Flow
0.060.10.06-0.14-0.02-0.05

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
--0.1-0.1-0.1-0.08-
Lease Payments
-0.06-0.1-0.1-0.1-0.08-
Net Debt Issued (Repaid)
-0.06-0.1-0.1-0.1-0.08-
Issuance of Common Stock
104.8624.7624.430.8722.8521.28
Other Financing Activities
-6.14-0.89-1.63--0.13-1.67
Financing Cash Flow
98.6623.7622.70.7722.6419.61

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-1.960.44-0.31-0.120.690.03
Net Cash Flow
71.124.85.61-10.795.5211.33

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-25.65-19.5-16.84-11.3-17.81-8.27
Free Cash Flow Growth
------
Free Cash Flow Per Share
-0.32-0.27-0.25-0.19-0.34-0.21
Levered Free Cash Flow
8.94-6.29-8.74-0.3-3-3.56
Unlevered Free Cash Flow
8.94-6.29-8.74-0.3-2.67-3.56
Free Cash Flow After Leases
-25.71-19.6-16.94-11.4-17.88-8.27

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
-3.150.660.84-0.242.110.43